Log in

ETR:SRTSartorius Stock Price, Forecast & News

€249.00
-7.00 (-2.73 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
€249.00
Now: €249.00
€256.00
50-Day Range
€239.00
MA: €262.22
€304.00
52-Week Range
€138.50
Now: €249.00
€314.00
Volume2,219 shs
Average VolumeN/A
Market Capitalization$8.52 billion
P/E Ratio108.64
Dividend Yield0.14%
BetaN/A
Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors. It also provides lab filtration and purification devices; sterile and virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, and integrity testing devices; and liquid storage and shipping, freeze and thaw, mixing, proven integrity, transferring and sampling, connecting and disconnecting, and final filling management products. In addition, the company offers process control and data analytics products, such as process analyzers, automation modules, and data analytics and chemometrics; and microbiology products, and lab water purification systems. Further, it provides lab balances, mass comparators and metrology, moisture analyzers, specialty weighing solutions, weighing accessories, weights/weight sets, paint mixing solutions, and OEM weigh cells; and OEM membrane and device, pipetting and dispensing, and connectivity solutions. Additionally, the company offers bioprocess development engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, food and beverage, environmental, and paint mixing industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Read More
Sartorius logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.57 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone49 551 308 0

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.90 billion
Cash Flow€2.33 per share
Book Value€11.85 per share

Profitability

Miscellaneous

Employees8,125
Market Cap$8.52 billion
Next Earnings Date7/21/2020 (Estimated)
OptionableOptionable

Receive SRT News and Ratings via Email

Sign-up to receive the latest news and ratings for SRT and its competitors with MarketBeat's FREE daily newsletter.

Sartorius (ETR:SRT) Frequently Asked Questions

How has Sartorius' stock been impacted by COVID-19 (Coronavirus)?

Sartorius' stock was trading at €182.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SRT stock has increased by 36.8% and is now trading at €249.00. View which stocks have been most impacted by Coronavirus.

When is Sartorius' next earnings date?

Sartorius is scheduled to release its next quarterly earnings announcement on Tuesday, July 21st 2020. View our earnings forecast for Sartorius.

Has Sartorius been receiving favorable news coverage?

News stories about SRT stock have trended neutral recently, according to InfoTrie. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sartorius earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about Sartorius.

Who are some of Sartorius' key competitors?

What other stocks do shareholders of Sartorius own?

Who are Sartorius' key executives?

Sartorius' management team includes the following people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 54)
  • Mr. Rainer Lehmann, CFO & Member of Exec. Board and Head of Fin., Information Technology & Bus. Process (Age 43)
  • Ms. Petra Kirchhoff, Head of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 50)
  • Mr. Gerry Mackay, Head of Lab Products & Services Division & Member of Exec. Board (Age 56)
  • Dr. René Fáber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 43)

What is Sartorius' stock symbol?

Sartorius trades on the ETR under the ticker symbol "SRT."

What is Sartorius' stock price today?

One share of SRT stock can currently be purchased for approximately €249.00.

How big of a company is Sartorius?

Sartorius has a market capitalization of $8.52 billion and generates $1.90 billion in revenue each year. Sartorius employs 8,125 workers across the globe.

What is Sartorius' official website?

The official website for Sartorius is www.sartorius.com.

How can I contact Sartorius?

The company can be reached via phone at 49 551 308 0.

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.